KR960005145B1 - 고혈압 및 울혈성 심부전증 치료용 약학적 조성물 - Google Patents

고혈압 및 울혈성 심부전증 치료용 약학적 조성물 Download PDF

Info

Publication number
KR960005145B1
KR960005145B1 KR1019870012319A KR870012319A KR960005145B1 KR 960005145 B1 KR960005145 B1 KR 960005145B1 KR 1019870012319 A KR1019870012319 A KR 1019870012319A KR 870012319 A KR870012319 A KR 870012319A KR 960005145 B1 KR960005145 B1 KR 960005145B1
Authority
KR
South Korea
Prior art keywords
alkyl
carbon atoms
heart failure
congestive heart
component
Prior art date
Application number
KR1019870012319A
Other languages
English (en)
Korean (ko)
Other versions
KR880006197A (ko
Inventor
시글 헬렌
파울 호프 로버트
Original Assignee
산도즈 리미티드
예안 크라메르·한스 루돌프하우스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by 산도즈 리미티드, 예안 크라메르·한스 루돌프하우스 filed Critical 산도즈 리미티드
Publication of KR880006197A publication Critical patent/KR880006197A/ko
Application granted granted Critical
Publication of KR960005145B1 publication Critical patent/KR960005145B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019870012319A 1986-11-03 1987-11-02 고혈압 및 울혈성 심부전증 치료용 약학적 조성물 KR960005145B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8626217 1986-11-03
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB8713349 1987-06-08
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
KR880006197A KR880006197A (ko) 1988-07-22
KR960005145B1 true KR960005145B1 (ko) 1996-04-22

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870012319A KR960005145B1 (ko) 1986-11-03 1987-11-02 고혈압 및 울혈성 심부전증 치료용 약학적 조성물

Country Status (25)

Country Link
KR (1) KR960005145B1 (fr)
AT (1) AT397343B (fr)
AU (1) AU615883B2 (fr)
BE (1) BE1002063A4 (fr)
CA (1) CA1314222C (fr)
CH (1) CH677189A5 (fr)
DE (1) DE3736505A1 (fr)
DK (1) DK574087A (fr)
ES (1) ES2010524A6 (fr)
FI (1) FI874823A (fr)
FR (1) FR2605885B1 (fr)
GR (1) GR871680B (fr)
HK (1) HK138893A (fr)
HU (1) HU199681B (fr)
IE (1) IE60496B1 (fr)
IL (1) IL84343A (fr)
IT (1) IT1212037B (fr)
LU (1) LU87034A1 (fr)
MY (1) MY102124A (fr)
NL (1) NL8702502A (fr)
NO (1) NO874539L (fr)
NZ (1) NZ222401A (fr)
PH (1) PH23249A (fr)
PT (1) PT86062B (fr)
SE (1) SE8704272L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
IE60496B1 (en) 1994-07-27
IE872951L (en) 1988-05-03
AU8057687A (en) 1988-05-05
KR880006197A (ko) 1988-07-22
MY102124A (en) 1992-03-31
ATA286987A (de) 1993-08-15
IL84343A0 (en) 1990-02-09
FR2605885A1 (fr) 1988-05-06
HK138893A (en) 1993-12-24
GR871680B (en) 1988-05-02
PT86062B (pt) 1990-11-07
DK574087A (da) 1988-05-04
NO874539L (no) 1988-05-04
IT8748553A0 (it) 1987-10-30
SE8704272L (sv) 1988-05-04
BE1002063A4 (fr) 1990-06-12
FI874823A0 (fi) 1987-11-02
NL8702502A (nl) 1988-06-01
NO874539D0 (no) 1987-11-02
DE3736505A1 (de) 1988-05-05
AT397343B (de) 1994-03-25
PT86062A (en) 1987-12-01
CH677189A5 (fr) 1991-04-30
CA1314222C (fr) 1993-03-09
HUT47847A (en) 1989-04-28
LU87034A1 (fr) 1988-05-03
FR2605885B1 (fr) 1993-09-10
DK574087D0 (da) 1987-11-02
SE8704272D0 (sv) 1987-11-02
HU199681B (en) 1990-03-28
IT1212037B (it) 1989-11-08
ES2010524A6 (es) 1989-11-16
AU615883B2 (en) 1991-10-17
NZ222401A (en) 1991-04-26
PH23249A (en) 1989-06-16
IL84343A (en) 1993-07-08
FI874823A (fi) 1988-05-04

Similar Documents

Publication Publication Date Title
US4703038A (en) Combination of dihydropyridines with angiotensin converting enzymes-inhibitors
EP1345607B1 (fr) Combinaison therapeutique d'amlodipine et de benazepril / benazeprilate
EP1061952A2 (fr) Combinaison d'un agoniste inverse alpha 5 gaba-a et inhibiteur d'acetylcholinesterase
JP2002537258A5 (fr)
EP0425909A2 (fr) Méthode pour restaurer l'activité vasorelaxante des artères coronaires, amoindrie par l'athérosclérose ou l'hypercholestérolémie, en utilisant un inhibiteur de l'ACE
JPH0334926A (ja) 抗不安薬
US4859665A (en) Antihypertensive combination products containing a dihydropyridine and a pyridazodiazepine
KR960005145B1 (ko) 고혈압 및 울혈성 심부전증 치료용 약학적 조성물
KR930009786B1 (ko) 특정 paf 길항제/항히스타민제 조성물
AU752013B2 (en) Combination of a GABA-A alpha 5 inverse agonist and a nicotinic agonist
US4157394A (en) Cardio-protective pharmaceutical composition
US4442112A (en) Dihydropyridine derivatives useful in treating vascular headaches
US4617306A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
CA1255596A (fr) Produit pharmaceutique a teneur de dihydropyridine
EP0381074A2 (fr) Méthode pour suivre un régime de façon plus aisée, en utilisant un inhibiteur de l'enzyme de conversion de l'angiotensine
US5334592A (en) Certain PAF antagonist antihistamine combinations and methods
JP5559696B2 (ja) 糖尿病性腎症の治療剤
US4363809A (en) Organic compounds
JPS63132835A (ja) 高血圧およびうっ血性心不全用医薬組成物
JPH07304689A (ja) 劇症肝炎ならびに急性肝不全治療剤
US20040048905A1 (en) Therapeutic combination of amlodipine and benazepril
GB2198641A (en) Pharmaceutical cardiac compositions containing calcium antagonists
CZ367598A3 (cs) Použití substituovaného azaspiranu
ZA200304330B (en) Therapeutic combination of amlodipine and benazepril.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee